Embecta Corp
Open
SectorHealthcare
6.17 -0.64
Overview
Share price change
24h
Min
5.9
Max
6.23
Income | 25M 21M |
|---|---|
Sales | 50M 272M |
P/E Sector Avg | 4.065 48.735 |
EPS | 0.56 |
Dividend yield | 7.68 |
Profit margin | 7.766 |
Employees | 1,850 |
EBITDA | 20M 65M |
Dividend yield Sector Avg | 7.68% 2.24% |
|---|---|
Next Earnings | 24 Nov 2026 |
Next Dividend date | 17 Dec 2026 |
Next Ex Dividend date | 4 Dec 2026 |
Market Cap | 118M 339M |
|---|---|
Previous open | 6.81 |
Previous close | 6.17 |
Embecta Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Embecta Corp Forecast
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Embecta Corp
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.